Thursday
Mar312016

NCT00558051

Alpha-type-1 Dendritic Cell-based Vaccines in Patients With Metastatic Colorectal Cancer

Phase I Evaluation of Semi-continuous Alpha-type-1 Dendritic Cell-based Vaccines in Patients With Metastatic Colorectal Cancer

Condition: Metastatic Colorectal Cancer
Sponsor: Pawel Kalisnki, Universiy of Pittsburgh

Phase 1

Relates to JIC Article April 2016

PrintView Printer Friendly Version

EmailEmail Article to Friend